Responses
Oral Sessions
Clinical sciences oral session 5—treatment: Syphilis, Herpes, &
O3-S5.01 Impact of AIC316, a novel antiviral helicase-primase inhibitor, on genital HSV shedding: randomised, double-blind, placebo-controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.